Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

morphine

MORPHINE JUNO

morphine (MORPHINE JUNO) is a mu opioid receptor agonist. Associated with Lacuna Pharma Pty Ltd.

TGA: approved
Patents linked 14
Pipeline programs 27
News articles 0
Drug details — morphine
Class
—
Route
—
Patents
14
Programs
27
Data quality
0.81
← All drugs Manufacturer profile Related patents Pipeline programs Drug news hub Event calendar

Quick answer

morphine (MORPHINE JUNO) is a mu opioid receptor agonist. Associated with Lacuna Pharma Pty Ltd.

Key facts

INN morphine
Brand MORPHINE JUNO
Mechanism Mu opioid receptor agonist
Originator Lacuna Pharma Pty Ltd

Mechanism of action

Mu opioid receptor agonist

Approval history

Authority Status Date
TGA approved —

Pipeline programs

Browse pipeline Sponsor programs
  1. APHP 180610 Phase 3 · PARItec · Acute Myocardial Infarction
  2. APHP 180610 Phase 3 · PARItec · Acute Myocardial Infarction
  3. APHP 230842 Phase 3 · PARItec · patients with chronic respiratory insufficiency due to amyot
  4. APHP211035 Phase 3 · PARItec · vaso-occlusive crisis due to sickle cell disease
  5. APHP211044 Phase 3 · PARItec · urgency, limb injuries
  6. apomorphine infusion Phase 3 · SUPERNUS PHARMACEUTICALS · Idiopathic Parkinson's Disease
  7. Morphine Phase 2 · Hospital Authority · Respiratory Depression
  8. DepoDur (extended-release epidural morphine) Phase 1 · Pacira Ireland · Postoperative Pain

Related patents

Browse patents Lacuna Pharma Pty Ltd patent hub

  1. US 12383625

    Polyoxazoline-drug conjugates with novel pharmacokinetic properties

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12383626

    Polyoxazoline-drug conjugates with novel pharmacokinetic properties

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12233132

    Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including same

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11925689

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11213588

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10864276

    Activated polyoxazolines and conjugates and compositions comprising the same

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10166294

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10086084

    Activated polyoxazolines and conjugates and compositions comprising the same

    Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9169354

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8501899

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8110651

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8101706

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8088884

    Multi-armed forms of activated polyoxazoline and methods of synthesis thereof

    Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7943141

    Activated polyoxazolines and compositions comprising the same

    Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is morphine?

morphine (MORPHINE JUNO) is a mu opioid receptor agonist. Associated with Lacuna Pharma Pty Ltd.

What is the brand name for morphine?

MORPHINE JUNO is a marketed brand name for morphine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.